Data / Form D filings / IVIEW Therapeutics, Inc.
IVIEW Therapeutics, Inc.: Form D filings
IVIEW Therapeutics, Inc., a biotechnology company in Cranbury, NJ, filed 5 Form D notices with the SEC between 2021 and 2025. The latest, on June 10, 2025, reports $9.2 million sold of a $15 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5 Cedar Brook Drive, Cranbury, NJ, 08512
- Phone
- (609) 773-8580
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1848749
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | Amendment | $15,000,000 | $9,177,371 | $5,822,629 | 5 | May 14, 2024 | sec.gov |
| Feb 24, 2025 | Amendment | $15,000,000 | $7,677,371 | $7,322,629 | 4 | May 14, 2024 | sec.gov |
| May 24, 2024 | New notice | $15,000,000 | $715,000 | $14,285,000 | 1 | May 14, 2024 | sec.gov |
| Jan 12, 2022 | Amendment | $30,027,445 | $30,027,445 | 15 | Feb 26, 2021 | sec.gov | |
| Mar 12, 2021 | New notice | $24,027,446 | $6,981,668 | $17,045,778 | 6 | Feb 26, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Qi Zhu | Director | |
| Houman Hemmati | Executive Officer, Director | |
| Wei Wang | Executive Officer, Director | |
| Jingjie Li | Director | |
| Xiaolu Sun | Director | |
| Bo Liang | Executive Officer, Director | |
| Bin He | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
- Bullseye Biodevices, Inc. $1.3 million · Aug 10, 2026
- Hepion Pharmaceuticals, Inc. $3.1 million · Aug 5, 2026
Every Form D from the week of Jun 9, 2025 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what IVIEW Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.